MU has launched its first clinical trial using reactor-made Eye90 microspheres to target inoperable liver tumors with precision radiotherapy.

Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score that predicts the risk of liver cancer. Published in the scientific journal ...

PLT012 received FDA fast track status for liver cancer, with an ongoing trial evaluating safety and early activity of the CD36-targeting immunotherapy.

New research shows that reducing dietary protein may significantly lower liver cancer risk or slow its progression in people ...

Scientists have identified a hidden barrier that prevents immunotherapy from working against a rare liver cancer. Immunotherapy, which activates the body’s own immune system to kill cancer cells, has ...

Researchers found that distinct tumor clones in uveal melanoma determine where metastases form. Clones with BAP1 mutations ...

Persistently elevated liver enzymes may be caused by certain types of cancer, including liver, colon, breast, stomach, pancreas, and skin cancers. Liver enzymes are proteins produced by your liver.